BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22901129)

  • 21. MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.
    Zhao X; Duan Z; Liu X; Wang B; Wang X; He J; Yao Z; Yang J
    Anat Rec (Hoboken); 2013 Dec; 296(12):1842-9. PubMed ID: 24155205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of Mcl-1 by SRSF1 and SRSF5 in cancer cells.
    Gautrey HL; Tyson-Capper AJ
    PLoS One; 2012; 7(12):e51497. PubMed ID: 23284704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth.
    Ueyama K; Ikeda K; Sato W; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
    Cancer Gene Ther; 2010 Sep; 17(9):624-32. PubMed ID: 20467453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the NOB1 gene and its clinical significance in papillary thyroid carcinoma.
    Lin S; Meng W; Zhang W; Liu J; Wang P; Xue S; Chen G
    J Int Med Res; 2013 Jun; 41(3):568-72. PubMed ID: 23685895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NOB1 silencing inhibits the growth and metastasis of laryngeal cancer cells through the regulation of JNK signaling pathway.
    Gao X; Wang J; Bai W; Ji W; Wang L
    Oncol Rep; 2016 Jun; 35(6):3313-20. PubMed ID: 27035645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lentivirus-mediated knockdown of CEP55 suppresses cell proliferation of breast cancer cells.
    Wang Y; Jin T; Dai X; Xu J
    Biosci Trends; 2016 Feb; 10(1):67-73. PubMed ID: 26902787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of NOB1 expression in breast infiltrating ductal carcinoma.
    Li XY; Luo QF; Li J; Wei CK; Kong XJ; Zhang JF; Fang L
    Int J Clin Exp Pathol; 2013; 6(10):2137-44. PubMed ID: 24133592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of down-regulation of CC chemokine ligand 5 (CCL5) on proliferation of human breast cancer cells in vitro].
    Kuang JX; Wang WX; Sun SR; Wang WR; Yao XL
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):174-7. PubMed ID: 21575514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1).
    Zhou J; Xu T; Yan Y; Qin R; Wang H; Zhang X; Huang Y; Wang Y; Lu Y; Fu D; Chen J
    PLoS One; 2013; 8(7):e68469. PubMed ID: 23869222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein.
    Wu L; Hui H; Wang LJ; Wang H; Liu QF; Han SX
    Oncol Rep; 2015 May; 33(5):2309-18. PubMed ID: 25760058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of the c-Jun-N-terminal kinase expression by siRNA inhibits MCF-7 breast carcinoma cell line growth.
    Parra E; Ferreira J
    Oncol Rep; 2010 Nov; 24(5):1339-45. PubMed ID: 20878129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of COX-2 expression by recombinant adenovirus shRNA attenuates the malignant biological behavior of breast cancer cells.
    Tu B; Ma TT; Peng XQ; Wang Q; Yang H; Huang XL
    Asian Pac J Cancer Prev; 2014; 15(20):8829-36. PubMed ID: 25374215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing the Peroxiredoxin III gene inhibits cell proliferation in breast cancer.
    Chua PJ; Lee EH; Yu Y; Yip GW; Tan PH; Bay BH
    Int J Oncol; 2010 Feb; 36(2):359-64. PubMed ID: 20043069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NOB1: A Potential Biomarker or Target in Cancer.
    Ke W; Lu Z; Zhao X
    Curr Drug Targets; 2019; 20(10):1081-1089. PubMed ID: 30854959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibition of cellular proliferation by knockdown of MARCH6 gene expression in breast cancer cells].
    Shen N; Wang Y; Zhou W; Wang Z; Tu Q; Jiang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 41(10):1009-1015. PubMed ID: 27807321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive nin one binding protein expression predicts poor outcome in prostate cancer.
    Chen J; Wang J; Cui X; Liu Y; Yin L; Li Y; Chen L; Xu D; Gao Y
    Mol Med Rep; 2015 Apr; 11(4):2671-6. PubMed ID: 25503472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways.
    Ahmad A; Wang Z; Kong D; Ali R; Ali S; Banerjee S; Sarkar FH
    Breast Cancer Res Treat; 2011 Feb; 126(1):15-25. PubMed ID: 20379844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ER81-shRNA inhibits growth of triple-negative human breast cancer cell line MDA-MB-231 in vivo and in vitro.
    Chen Y; Zou H; Yang LY; Li Y; Wang L; Hao Y; Yang JL
    Asian Pac J Cancer Prev; 2012; 13(5):2385-92. PubMed ID: 22901226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer.
    Guan H; Dai Z; Ma Y; Wang Z; Liu X; Wang X
    Int J Mol Med; 2016 Jun; 37(6):1643-51. PubMed ID: 27082308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein.
    Sun J; Fan Z; Lu S; Yang J; Hao T; Huo Q
    Int J Mol Med; 2016 Feb; 37(2):485-92. PubMed ID: 26743688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.